Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Whooping Cough 1Urinary Bladder Neoplasms 1Pneumococcal Infections 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Measles 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatitis B 1HIV Infections 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Rituximab 32fludarabine phosphate 28Cyclophosphamide 26Filgrastim 13Peripheral Blood Stem Cell Transplantation 12ibrutinib 11Bortezomib 11Lenalidomide 10alvocidib 9Cyclosporine 9tanespimycin 8Biopsy 8fludarabine 7Vincristine 7Radiotherapy 7Etoposide 7Specimen Handling 6romidepsin 5bryostatin 1 5apolizumab 5Vorinostat 5Methotrexate 5Ifosfamide 5Cytarabine 5CT-P10 5Busulfan 5temsirolimus 4laromustine 4aldesleukin 4Thalidomide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Lymphocytic, Chronic, B-Cell × Pneumococcal Vaccines × Clear all
NCT01351896 2026-05-27

Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
49 enrolled 34 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡